Free Account Opening + AMC Free Demat
Loading...

Bafna Pharmaceuticals IPO vs Gokul Refoils IPO

Comparision between Bafna Pharmaceuticals IPO and Gokul Refoils IPO.

IPO Details

Bafna Pharmaceuticals IPO is a Mainline Book Built Issue IPO proposed to list at BSE while Gokul Refoils IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

  Bafna Pharmaceuticals IPO Gokul Refoils IPO
Logo Bafna Pharmaceuticals IPO Logo Gokul Refoils IPO Logo
Issue Category Mainline Mainline
Issue Type IPO IPO
Process Type Fixed Price Issue Book Built Issue
Listing At BSE BSE, NSE
Lead Managers Keynote Financial Services Ltd

Ashika Capital Ltd
Anand Rathi Securities Limited

Intensive Fiscal Services Private Limited
Registrar Cameo Corporate Services Limited Link Intime India Private Ltd
Market Maker
DRHP DRHP DRHP
RHP RHP RHP
Anchor Investor
IPO Allotment URL IPO Allotment URL IPO Allotment URL

Issue Size and Price

The total issue size of Bafna Pharmaceuticals IPO is up to ₹25.60 Cr whereas the issue size of the Gokul Refoils IPO is up to ₹139.59 Cr. The final issue price of Bafna Pharmaceuticals IPO is ₹40.00 per share and of Gokul Refoils IPO is ₹195.00 per share.

  Bafna Pharmaceuticals IPO Gokul Refoils IPO
Face Value ₹10 per share ₹10 per share
Issue Price (Lower) ₹175.00 per share
Issue Price (Upper) ₹195.00 per share
Issue Price (Final) ₹40.00 per share ₹195.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size 35 shares
Fresh Issue Size
Fresh Issue Size (Amount)
OFS Issue Size
OFS Issue Size (Amount)
Issue Size Total 64,00,000 shares 71,58,392 shares
Issue Size Total (Amount) up to ₹25.60 Cr up to ₹139.59 Cr

IPO Timetable

Bafna Pharmaceuticals IPO opens on May 27, 2008, while Gokul Refoils IPO opens on May 08, 2008. The closing date of Bafna Pharmaceuticals IPO and Gokul Refoils IPO is May 30, 2008, and May 13, 2008, respectively.

  Bafna Pharmaceuticals IPO Gokul Refoils IPO
Anchor Bid Date
Issue Open May 27, 2008 May 08, 2008
Issue Close May 30, 2008 May 13, 2008
Basis Of Allotment (Tentative)
Initiation of Refunds (Tentative)
Credit of Share (Tentative)
Listing date (Tentative)
Anchor Lockin End date 1
Anchor Lockin End date 2

Financials

Bafna Pharmaceuticals IPO P/E ratio is , as compared to Gokul Refoils IPO P/E ratio of .

  Bafna Pharmaceuticals IPO Gokul Refoils IPO
Financial
ParticularsFor the year/period ended (Rs. in lacs)
 30-Jun-0731-Mar-0731-Mar-0631-Mar-0531-Mar-04
  Total Income432.023861.962136.472662.651521.33
  Profit After Tax (PAT)49.70104.2392.2789.8144.51
ParticularsFor the year/period ended (Rs. in lacs)
 31-Mar-0731-Mar-0631-Mar-0531-Mar-04
  Total Income160,002.97125,829.99112,098.5350,304.94
  Profit After Tax (PAT)2,671.391,094.781,782.521,365.82
Promoter Shareholding (Pre-Issue) 71.07% 95.74%
Promoter Shareholding (Post-Issue) 42.6% 69.76%
P/E Ratio
Market Cap
ROE
ROCE
Debt/Equity
EPS
RoNW 10.65%% 20%%

Shares Offered

In the Bafna Pharmaceuticals IPO retail investors (RII) are offered while in Gokul Refoils IPO retail investors are offered . Qualified institutional buyers (QIB) are offered in Bafna Pharmaceuticals IPO and in Gokul Refoils IPO.

  Bafna Pharmaceuticals IPO Gokul Refoils IPO
Anchor Investor Reserveration
Market Maker Reserveration
QIB
NII
RII
Employee
Others
Total

Bids Received (Subscription)

Bafna Pharmaceuticals IPO subscribed in total, whereas Gokul Refoils IPO subscribed 4.27x.

  Bafna Pharmaceuticals IPO Gokul Refoils IPO
QIB (times) 2.72x
NII (times) 6.58x
Big NII (times)
Small NII (times)
RII (times) 5.59x
Employee (times) 1.06x
Other (times)
Total (times) 4.27x

Comments

Add a public comment...